Proceedings of the Canadian Frailty Network Workshop: Identifying Biomarkers of Frailty to Support Frailty Risk Assessment, Diagnosis and Prognosis. Toronto, January 15, 2018

  • John MuscedereEmail author
  • P. M. Kim
  • J. Afilalo
  • C. Balion
  • V. E. Baracos
  • D. Bowdish
  • M. Cesari
  • J. D. Erusalimsky
  • T. Fülöp
  • G. Heckman
  • S. E. Howlett
  • R. G. Khadaroo
  • J. L. Kirkland
  • L. Rodriguez Mañas
  • E. Marzetti
  • G. Paré
  • P. Raina
  • K. Rockwood
  • A. Sinclair
  • C. Skappak
  • C. Verschoor
  • S. Walter
  • Canadian Frailty Network
Special Article


The Canadian Frailty Network (CFN), a pan-Canadian not-for-profit organization funded by the Government of Canada through the Networks of Centres of Excellence Program, is dedicated to improving the care of older Canadians living with frailty. The CFN has partnered with the Canadian Longitudinal Study on Aging (CLSA) to measure potential frailty biomarkers in biological samples (whole blood, plasma, urine) collected in over 30,000 CLSA participants. CFN hosted a workshop in Toronto on January 15 2018, bringing together experts in the field of biomarkers, aging and frailty. The overall objectives of the workshop were to start building a consensus on potential frailty biomarker domains and identify specific frailty biomarkers to be measured in the CLSA biological samples. The workshop was structured with presentations in the morning to frame the discussions for the afternoon session, which was organized as a free-flowing discussion to benefit from the expertise of the participants. Participants and speakers were from Canada, Italy, Spain, United Kingdom and the United States. Herein we provide pertinent background information, a summary of all the presentations with key figures and tables, and the distillation of the discussions. In addition, moving forward, the principles CFN will use to approach frailty biomarker research and development are outlined. Findings from the workshop are helping CFN and CLSA plan and conduct the analysis of biomarkers in the CLSA samples and which will inform a follow-up data access competition.

Key words

CFN CLSA frailty frailty index seniors older adults biomarkers aging 


  1. 1.
    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.Google Scholar
  2. 2.
    Shamliyan T, Talley KM, Ramakrishnan R, Kane RL. Association of frailty with survival: a systematic literature review. Ageing Res Rev. 2013;12(2):719–36.Google Scholar
  3. 3.
    Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59(3):255–63.Google Scholar
  4. 4.
    Bagshaw SM, Stelfox HT, McDermid RC, Rolfson DB, Tsuyuki RT, Baig N, et al. Association between frailty and short- and long-term outcomes among critically ill patients: a multicentre prospective cohort study. CMAJ. 2014;186(2):E95–102.Google Scholar
  5. 5.
    Rockwood K, Howlett SE. Fifteen years of progress in understanding frailty and health in aging. BMC Med. 2018;16(1):220.Google Scholar
  6. 6.
    Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, et al. Frailty: an emerging research and clinical paradigm—issues and controversies. J Gerontol A Biol Sci Med Sci. 2007;62(7):731–7.Google Scholar
  7. 7.
    Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal. 2001;1:323–36.Google Scholar
  8. 8.
    Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24.Google Scholar
  9. 9.
    Rockwood K, Blodgett JM, Theou O, Sun MH, Feridooni HA, Mitnitski A, et al. A Frailty Index Based On Deficit Accumulation Quantifies Mortality Risk in Humans and in Mice. Sci Rep. 2017;7:43068.Google Scholar
  10. 10.
    Clegg A, Bates C, Young J, Ryan R, Nichols L, Ann Teale E, et al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45(3):353–60.Google Scholar
  11. 11.
    Sternberg SA, Wershof Schwartz A, Karunananthan S, Bergman H, Mark Clarfield A. The identification of frailty: a systematic literature review. J Am Geriatr Soc. 2011;59(11):2129–38.Google Scholar
  12. 12.
    Cesari M, Gambassi G, van Kan GA, Vellas B. The frailty phenotype and the frailty index: different instruments for different purposes. Age Ageing. 2014;43(1):10–2.Google Scholar
  13. 13.
    Abbasi M, Rolfson D, Khera AS, Dabravolskaj J, Dent E, Xia L. Identification and management of frailty in the primary care setting. CMAJ. 2018;190(38):E1134–E40.Google Scholar
  14. 14.
    Gilardi F, Capanna A, Ferraro M, Scarcella P, Marazzi MC, Palombi L, et al. Frailty screening and assessment tools: a review of characteristics and use in Public Health. Ann Ig. 2018;30(2):128–39.Google Scholar
  15. 15.
    Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: A review. Eur J Intern Med. 2016;31:3–10.Google Scholar
  16. 16.
    de Vries NM, Staal JB, van Ravensberg CD, Hobbelen JS, Olde Rikkert MG, Nijhuisvan der Sanden MW. Outcome instruments to measure frailty: a systematic review. Ageing Res Rev. 2011;10(1):104–14.Google Scholar
  17. 17.
    Howlett SE, Rockwood MR, Mitnitski A, Rockwood K. Standard laboratory tests to identify older adults at increased risk of death. BMC Med. 2014;12:171.Google Scholar
  18. 18.
    Mitnitski A, Collerton J, Martin-Ruiz C, Jagger C, von Zglinicki T, Rockwood K, et al. Age-related frailty and its association with biological markers of ageing. BMC Med. 2015;13:161.Google Scholar
  19. 19.
    Sylman JL, Mitrugno A, Atallah M, Tormoen GW, Shatzel JJ, Tassi Yunga S, et al. The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis. Front Oncol. 2018;8:78.Google Scholar
  20. 20.
    Yu IS, Cheung WY. A Contemporary Review of the Treatment Landscape and the Role of Predictive and Prognostic Biomarkers in Pancreatic Adenocarcinoma. Can J Gastroenterol Hepatol. 2018;2018:1863535.Google Scholar
  21. 21.
    Shang J, Yamashita T, Fukui Y, Song D, Li X, Zhai Y, et al. Different Associations of Plasma Biomarkers in Alzheimer’s Disease, Mild Cognitive Impairment, Vascular Dementia, and Ischemic Stroke. J Clin Neurol. 2018;14(1):29–34.Google Scholar
  22. 22.
    Chen RY, Via LE, Dodd LE, Walzl G, Malherbe ST, Loxton AG, et al. Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial. Gates Open Res. 2017;1:9.Google Scholar
  23. 23.
    Kostikas K, Brindicci C, Patalano F. Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD. Curr Drug Targets. 2018;19(16):1882–96.Google Scholar
  24. 24.
    Kanters DM, Griffith LE, Hogan DB, Richardson J, Patterson C, Raina P. Assessing the measurement properties of a Frailty Index across the age spectrum in the Canadian Longitudinal Study on Aging. J Epidemiol Community Health. 2017;71(8):794–9.Google Scholar
  25. 25.
    van Iersel MB, Rikkert MG. Frailty criteria give heterogeneous results when applied in clinical practice. J Am Geriatr Soc. 2006;54(4):728–9.Google Scholar
  26. 26.
    Kehler DS, Ferguson T, Stammers AN, Bohm C, Arora RC, Duhamel TA, et al. Prevalence of frailty in Canadians 18–79 years old in the Canadian Health Measures Survey. Bmc Geriatr. 2017;17(1):28.Google Scholar
  27. 27.
    Atkinson A, Jr; Magnuson, Warren G.; Colburn, Wayne A.; DeGruttola, Victor G; DeMets, David L.; Downing, Gregory J; Hoth, DanielF; Oates, John A; Peck, Carl C; Schooley, Robert T; Spilker, Bert A; Woodcock, Janet; Zeger, Scott L. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89–95.Google Scholar
  28. 28.
    Jha SR, Hannu MK, Newton PJ, Wilhelm K, Hayward CS, Jabbour A, et al. Reversibility of Frailty After Bridge-to-Transplant Ventricular Assist Device Implantation or Heart Transplantation. Transplant Direct. 2017;3(7):e167.Google Scholar
  29. 29.
    Gustavson AM, Falvey JR, Jankowski CM, Stevens-Lapsley JE. Public Health Impact of Frailty: Role of Physical Therapists. J Frailty Aging. 2017;6(1):2–5.Google Scholar
  30. 30.
    Mosquera C, Spaniolas K, Fitzgerald TL. Impact of frailty on surgical outcomes: The right patient for the right procedure. Surgery. 2016;160(2):272–80.Google Scholar
  31. 31.
    Sepehri A, Beggs T, Hassan A, Rigatto C, Shaw-Daigle C, Tangri N, et al. The impact of frailty on outcomes after cardiac surgery: a systematic review. J Thorac Cardiovasc Surg. 2014;148(6):3110–7.Google Scholar
  32. 32.
    Fagard K, Leonard S, Deschodt M, Devriendt E, Wolthuis A, Prenen H, et al. The impact of frailty on postoperative outcomes in individuals aged 65 and over undergoing elective surgery for colorectal cancer: A systematic review. J Geriatr Oncol. 2016;7(6):479–91.Google Scholar
  33. 33.
    Lee L, Patel T, Hillier LM, Maulkhan N, Slonim K, Costa A. Identifying frailty in primary care: A systematic review. Geriatr Gerontol Int. 2017;17(10):1358–77.Google Scholar
  34. 34.
    Rockwood K, McMillan M, Mitnitski A, Howlett SE. A Frailty Index Based on Common Laboratory Tests in Comparison With a Clinical Frailty Index for Older Adults in Long-Term Care Facilities. J Am Med Dir Assoc. 2015;16(10):842–7.Google Scholar
  35. 35.
    Blodgett JM, Theou O, Howlett SE, Rockwood K. A frailty index from common clinical and laboratory tests predicts increased risk of death across the life course. Geroscience. 2017.Google Scholar
  36. 36.
    Ritt M, Jager J, Ritt JI, Sieber CC, Gassmann KG. Operationalizing a frailty index using routine blood and urine tests. Clin Interv Aging. 2017;12:1029–40.Google Scholar
  37. 37.
    Collerton J, Martin-Ruiz C, Davies K, Hilkens CM, Isaacs J, Kolenda C, et al. Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study. Mech Ageing Dev. 2012;133(6):456–66.Google Scholar
  38. 38.
    Fernandez-Garrido J, Ruiz-Ros V, Buigues C, Navarro-Martinez R, Cauli O. Clinical features of prefrail older individuals and emerging peripheral biomarkers: a systematic review. Arch Gerontol Geriatr. 2014;59(1):7–17.Google Scholar
  39. 39.
    Sanchez-Flores M, Marcos-Perez D, Costa S, Teixeira JP, Bonassi S, Pasaro E, et al. Oxidative stress, genomic features and DNA repair in frail elderly: A systematic review. Ageing Res Rev. 2017;37:1–15.Google Scholar
  40. 40.
    Soysal P, Isik AT, Carvalho AF, Fernandes BS, Solmi M, Schofield P, et al. Oxidative stress and frailty: A systematic review and synthesis of the best evidence. Maturitas. 2017;99:66–72.Google Scholar
  41. 41.
    Farrell SG, Mitnitski AB, Theou O, Rockwood K, Rutenberg AD. Probing the network structure of health deficits in human aging. Phys Rev E. 2018;98(3).Google Scholar
  42. 42.
    Rutenberg AD, Mitnitski AB, Farrell SG, Rockwood K. Unifying aging and frailty through complex dynamical networks. Exp Gerontol. 2018;107:126–9.Google Scholar
  43. 43.
    Parks RJ, Fares E, Macdonald JK, Ernst MC, Sinal CJ, Rockwood K, et al. A procedure for creating a frailty index based on deficit accumulation in aging mice. J Gerontol A Biol Sci Med Sci. 2012;67(3):217–27.Google Scholar
  44. 44.
    Whitehead JC, Hildebrand BA, Sun M, Rockwood MR, Rose RA, Rockwood K, et al. A clinical frailty index in aging mice: comparisons with frailty index data in humans. J Gerontol A Biol Sci Med Sci. 2014;69(6):621–32.Google Scholar
  45. 45.
    Kane AE, Keller KM, Heinze-Milne S, Grandy SA, Howlett SE. A Murine Frailty index based on Clinical and Laboratory Measurements: Links between Frailty and Pro-inflammatory Cytokines differ in a Sex-specific Manner. J Gerontol A Biol Sci Med Sci. 2018.Google Scholar
  46. 46.
    Jansen HJ, Moghtadaei M, Mackasey M, Rafferty SA, Bogachev O, Sapp JL, et al. Atrial structure, function and arrhythmogenesis in aged and frail mice. Sci Rep. 2017;7:44336.Google Scholar
  47. 47.
    Feridooni HA, Sun MH, Rockwood K, Howlett SE. Reliability of a Frailty Index Based on the Clinical Assessment of Health Deficits in Male C57BL/6J Mice. J Gerontol A Biol Sci Med Sci. 2015;70(6):686–93.Google Scholar
  48. 48.
    Kane AE, Hilmer SN, Boyer D, Gavin K, Nines D, Howlett SE, et al. Impact of Longevity Interventions on a Validated Mouse Clinical Frailty Index. J Gerontol A Biol Sci Med Sci. 2016;71(3):333–9.Google Scholar
  49. 49.
    Keller K, Kane A, Heinze-Milne S, Grandy SA, Howlett SE. Chronic treatment with the ACE inhibitor enalapril attenuates the development of frailty and differentially modifies pro-and anti-inflammatory cytokines in aging male and female C57BL/6 mice. J Gerontol A Biol Sci Med Sci. 2018.Google Scholar
  50. 50.
    Mamane S, Mullie L, Piazza N, Martucci G, Morais J, Vigano A, et al. Psoas Muscle Area and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The Montreal-Munich Study. Can J Cardiol. 2016;32(2):177–82.Google Scholar
  51. 51.
    Zuckerman J, Ades M, Mullie L, Trnkus A, Morin JF, Langlois Y, et al. Psoas Muscle Area and Length of Stay in Older Adults Undergoing Cardiac Operations. Ann Thorac Surg. 2017;103(5):1498–504.Google Scholar
  52. 52.
    Bibas L, Saleh E, Al-Kharji S, Chetrit J, Mullie L, Cantarovich M, et al. Muscle Mass and Mortality After Cardiac Transplantation. Transplantation. 2018;102(12):2101–7.Google Scholar
  53. 53.
    Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.Google Scholar
  54. 54.
    Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547–58.Google Scholar
  55. 55.
    Beaudart C, McCloskey E, Bruyere O, Cesari M, Rolland Y, Rizzoli R, et al. Sarcopenia in daily practice: assessment and management. Bmc Geriatr. 2016;16(1):170.Google Scholar
  56. 56.
    Penninx BW, Pahor M, Cesari M, Corsi AM, Woodman RC, Bandinelli S, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc. 2004;52(5):719–24.Google Scholar
  57. 57.
    Hong CH, Falvey C, Harris TB, Simonsick EM, Satterfield S, Ferrucci L, et al. Anemia and risk of dementia in older adults: findings from the Health ABC study. Neurology. 2013;81(6):528–33.Google Scholar
  58. 58.
    Chaves PH, Semba RD, Leng SX, Woodman RC, Ferrucci L, Guralnik JM, et al. Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women’s Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci. 2005;60(6):729–35.Google Scholar
  59. 59.
    Corti MC, Guralnik JM, Salive ME, Sorkin JD. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA. 1994;272(13):1036–42.Google Scholar
  60. 60.
    Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–7.Google Scholar
  61. 61.
    Robinson TN, Eiseman B, Wallace JI, Church SD, McFann KK, Pfister SM, et al. Redefining geriatric preoperative assessment using frailty, disability and co-morbidity. Ann Surg. 2009;250(3):449–55.Google Scholar
  62. 62.
    Afilalo J, Lauck S, Kim DH, Lefevre T, Piazza N, Lachapelle K, et al. Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study. J Am Coll Cardiol. 2017;70(6):689–700.Google Scholar
  63. 63.
    Zhou J, Huang P, Liu P, Hao Q, Chen S, Dong B, et al. Association of vitamin D deficiency and frailty: A systematic review and meta-analysis. Maturitas. 2016;94:70–6.Google Scholar
  64. 64.
    Bruyere O, Cavalier E, Buckinx F, Reginster JY. Relevance of vitamin D in the pathogenesis and therapy of frailty. Curr Opin Clin Nutr Metab Care. 2017;20(1):26–9.Google Scholar
  65. 65.
    Afilalo J. Androgen deficiency as a biological determinant of frailty: hope or hype? J Am Geriatr Soc. 2014; 62(6):1174–8.Google Scholar
  66. 66.
    Swiecicka A, Eendebak R, Lunt M, O’Neill TW, Bartfai G, Casanueva FF, et al. Reproductive Hormone Levels Predict Changes in Frailty Status in Community-Dwelling Older Men: European Male Ageing Study Prospective Data. J Clin Endocrinol Metab. 2018;103(2):701–9.Google Scholar
  67. 67.
    Hsu B, Cumming RG, Naganathan V, Blyth FM, Le Couteur DG, Seibel MJ, et al. Associations between circulating reproductive hormones and SHBG and prevalent and incident metabolic syndrome in community-dwelling older men: the Concord Health and Ageing in Men Project. J Clin Endocrinol Metab. 2014;99(12):E2686–91.Google Scholar
  68. 68.
    Srinivas-Shankar U, Roberts SA, Connolly MJ, O’Connell MD, Adams JE, Oldham JA, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2010;95(2):639–50.Google Scholar
  69. 69.
    Toma M, McAlister FA, Coglianese EE, Vidi V, Vasaiwala S, Bakal JA, et al. Testosterone supplementation in heart failure: a meta-analysis. Circ Heart Fail. 2012;5(3):315–21.Google Scholar
  70. 70.
    Neto WK, Gama EF, Rocha LY, Ramos CC, Taets W, Scapini KB, et al. Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies. Age (Dordr). 2015;37(1):9742.Google Scholar
  71. 71.
    Landi F, Cesari M, Calvani R, Cherubini A, Di Bari M, Bejuit R, et al. The “Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies” (SPRINTT) randomized controlled trial: design and methods. Aging Clin Exp Res. 2017;29(1):89–100.Google Scholar
  72. 72.
    Cesari M, Marzetti E, Calvani R, Vellas B, Bernabei R, Bordes P, et al. The need of operational paradigms for frailty in older persons: the SPRINTT project. Aging Clin Exp Res. 2017;29(1):3–10.Google Scholar
  73. 73.
    Warnier RM, van Rossum E, van Velthuijsen E, Mulder WJ, Schols JM, Kempen GI. Validity, Reliability and Feasibility of Tools to Identify Frail Older Patients in Inpatient Hospital Care: A Systematic Review. J Nutr Health Aging. 2016;20(2):218–30.Google Scholar
  74. 74.
    Lee L, Patel T, Costa A, Bryce E, Hillier LM, Slonim K, et al. Screening for frailty in primary care: Accuracy of gait speed and hand-grip strength. Can Fam Physician. 2017;63(1):e51–e7.Google Scholar
  75. 75.
    Lee LP, Tejal; Hillier, Loretta, M; Locklin, Jason; Milligan, James; Pefanis, John; Costa. Andrew; Lee, Joseph; Slonim, Karen; Giangregorio, Lora; Hunter, Susan; Keller, Heather; Boscart, Veronique Frailty Screening and Case-Finding for Complex Chronic Conditions in Older Adults in Primary Care. Geriatrics. 2018;3(3).Google Scholar
  76. 76.
    van Loon IN, Goto NA, Boereboom FTJ, Bots ML, Verhaar MC, Hamaker ME. Frailty Screening Tools for Elderly Patients Incident to Dialysis. Clin J Am Soc Nephrol. 2017;12(9):1480–8.Google Scholar
  77. 77.
    Rodriguez-Manas L, Fried LP. Frailty in the clinical scenario. Lancet. 2015;385(9968):e7–e9.Google Scholar
  78. 78.
    Tchkonia T, Kirkland JL. Aging, Cell Senescence, and Chronic Disease: Emerging Therapeutic Strategies. JAMA. 2018;320(13):1319–20.Google Scholar
  79. 79.
    Xu M, Pirtskhalava T, Farr JN, Weigand BM, Palmer AK, Weivoda MM, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018;24(8):1246–56.Google Scholar
  80. 80.
    Cardoso AL, Fernandes A, Aguilar-Pimentel JA, de Angelis MH, Guedes JR, Brito MA, et al. Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases. Ageing Res Rev. 2018;47:214–77.Google Scholar
  81. 81.
    Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012;60(8):1487–92.Google Scholar
  82. 82.
    Le Maguet P, Roquilly A, Lasocki S, Asehnoune K, Carise E, Saint Martin M, et al. Prevalence and impact of frailty on mortality in elderly ICU patients: a prospective, multicenter, observational study. Intensive Care Med. 2014;40(5):674–82.Google Scholar
  83. 83.
    Kojima G. Prevalence of Frailty in Nursing Homes: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2015;16(11):940–5.Google Scholar
  84. 84.
    Chong E, Ho E, Baldevarona-Llego J, Chan M, Wu L, Tay L. Frailty and Risk of Adverse Outcomes in Hospitalized Older Adults: A Comparison of Different Frailty Measures. J Am Med Dir Assoc. 2017;18(7):638 e7–e11.Google Scholar
  85. 85.
    Longo VD, Antebi A, Bartke A, Barzilai N, Brown-Borg HM, Caruso C, et al. Interventions to Slow Aging in Humans: Are We Ready? Aging Cell. 2015;14(4):497–510.Google Scholar
  86. 86.
    Newman JC, Covarrubias AJ, Zhao M, Yu X, Gut P, Ng CP, et al. Ketogenic Diet Reduces Midlife Mortality and Improves Memory in Aging Mice. Cell Metab. 2017; 26(3):547–57e8.Google Scholar
  87. 87.
    Lange KWL, Katharina M.; Makulska-Gertruda, Ewelina; Nakamura, Yukiko; Reissmann, Andreas; Kanaya, Shigehiko; Hausera, Joachim. Ketogenic diets and Alzheimer’s disease. Foo Science and Human Wellness. 2017;6(1):1–9.Google Scholar
  88. 88.
    Han YM, Bedarida T, Ding Y, Somba BK, Lu Q, Wang Q, et al. beta-Hydroxybutyrate Prevents Vascular Senescence through hnRNP A1-Mediated Upregulation of Oct4. Mol Cell. 2018;71(6):1064–78e5.Google Scholar

Copyright information

© Serdi and Springer Nature Switzerland AG 2019

Authors and Affiliations

  • John Muscedere
    • 1
    • 22
    Email author
  • P. M. Kim
    • 2
  • J. Afilalo
    • 3
  • C. Balion
    • 4
  • V. E. Baracos
    • 5
  • D. Bowdish
    • 4
  • M. Cesari
    • 6
    • 7
  • J. D. Erusalimsky
    • 8
  • T. Fülöp
    • 9
  • G. Heckman
    • 10
  • S. E. Howlett
    • 11
  • R. G. Khadaroo
    • 12
  • J. L. Kirkland
    • 13
  • L. Rodriguez Mañas
    • 14
  • E. Marzetti
    • 15
  • G. Paré
    • 4
  • P. Raina
    • 16
  • K. Rockwood
    • 17
  • A. Sinclair
    • 18
  • C. Skappak
    • 19
    • 20
  • C. Verschoor
    • 16
  • S. Walter
    • 21
  • Canadian Frailty Network
  1. 1.Department of Critical Care MedicineQueen’s UniversityKingstonCanada
  2. 2.Canadian Frailty NetworkKingstonCanada
  3. 3.Division of Cardiology and Centre for Clinical Epidemiology, Jewish General HospitalMcGill UniversityMontrealCanada
  4. 4.Department of Pathology and Molecular MedicineMcMaster UniversityHamiltonCanada
  5. 5.Department of OncologyUniversity of AlbertaEdmontonCanada
  6. 6.Department of Clinical Sciences and Community HealthUniversitá di MilanoMilanItaly
  7. 7.Fondazione IRCCS Ca’ Granda Ospedale Maggiore PoliclinicoMilanItaly
  8. 8.Department of Biomedical SciencesCardiff Metropolitan UniversityCardiffUK
  9. 9.Research Center on AgingUniversity of SherbrookeSherbrookeCanada
  10. 10.School of Public Health and Health Systems, Schlegel University of Waterloo Research Institute for AgingUniversity of WaterlooWaterlooCanada
  11. 11.Departments of Pharmacology and Medicine (Geriatric Medicine), Faculty of MedicineDalhousie UniversityHalifaxCanada
  12. 12.Department of Surgery and Critical Care MedicineUniversity of AlbertaEdmontonCanada
  13. 13.Robert and Arlene Kogod Center on AgingMayo ClinicRochesterUSA
  14. 14.Department of GeriatricsHospital Universitario de GetafeMadridSpain
  15. 15.Fondazione Policlinico Universitario «Agostino Gemelli» IRCCSUniversitá Cattolica del Sacro CuoreRomeItaly
  16. 16.Department of Health Research Methods, Evaluation and ImpactMcMaster UniversityHamiltonCanada
  17. 17.Division of Geriatric MedicineDalhousie UniversityHalifaxCanada
  18. 18.Foundation for Diabetes Research in Older People at Diabetes Frail LtdLutonUK
  19. 19.Schwartz/Reisman Emergency Medicine Institute, Mount Sinai HospitalUniversity of TorontoTorontoCanada
  20. 20.Division of Emergency MedicineMcMaster UniversityHamiltonCanada
  21. 21.Fundación de Investigación Biomédica Hospital Universitario de Getafe, Getafe, Spain. Dept. of Epidemiology and BiostatisticsUniversity of CaliforniaSan FranciscoUSA
  22. 22.Kingston Health Sciences CentreKingstonCanada

Personalised recommendations